We
We has been studied in 2 papers since 2020: 1 trial in people, 1 review. The newest paper, Feb 26, 2025: “Effects of different exercises on improving gait performance in patients with Parkinson's disease: a systematic review and network meta-analysis”.
2 papers study it2 findingsUpdated
At a glance
The findings reach people, from one lab or study. 1 lab in 2 countries.
“WE had no significant effect on VAT (P = 0.5)”
None of its findings points the other way.
- 1 lab in 2 countries
- Funders: UiT The Arctic University of Norway and 1 more
- Human trial1
Studies in people
1 study gave we to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on visceral adipose tissueP = 0.5 down: Decreases fat mass450 g (95% CI 37 to 836) | Randomized trial10 weeks | 77 peopleBoth70 yearsOlder adults | BMC geriatrics, May 12, 2020 |
What did studies of we find?
2Studies of we measured 2 outcomes: fat mass and visceral adipose tissue.
Fat mass
downin humans1
1 study
Fat mass
downin humans1
We decreases fat mass in humans (compared with wait-list control) (450 g (95% CI 37 to 836)).
Human trialcompared with wait-list control10 weeks
Visceral adipose tissue
no changein humans1
1 study
Visceral adipose tissue
no changein humans1
We showed no clear effect on visceral adipose tissue in humans (compared with wait-list control) (P = 0.5).
Human trialcompared with wait-list controlvisceral adipose tissue10 weeks